Pharmacologic Profile of SCH 530348, a Novel Oral Antiplatelet Agent Selective for the Protease-Activated Receptor-1 (PAR-1)

被引：0
|
作者：
Chintala, Madhu [1 ]
Ahn, Ho-Sam [1 ]
Foster, Carolyn [1 ]
Agans, Jacqueline [1 ]
Boykow, George [1 ]
机构：
[1] Schering Plough Rsch Inst, Kenilworth, NJ USA
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [21] Vorapaxar: a novel protease-activated receptor-1 inhibitor
    Gurbel, Paul A.
    Jeong, Young-Hoon
    Tantry, Udaya S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1445 - 1453
  • [22] Biological characterization of ER129614-06, a novel, non-peptide protease-activated receptor-1 (PAR-1) antagonist
    Kogushi, M
    Matsuoka, T
    Kobayashi, H
    Sato, N
    Suzuki, S
    Kawahara, T
    Kajiwara, A
    Hishinuma, I
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 245 - 246
  • [23] Protease-activated receptor-1 (PAR-1) increases intracellular calcium and mediates chloride secretion in an epithelial cell line
    Buresi, MC
    Schleihauf, E
    Vergnolle, N
    Chapman, K
    Buret, A
    Wallace, JL
    Hollenberg, MD
    MacNaughton, WK
    FASEB JOURNAL, 2000, 14 (04): : A114 - A114
  • [24] Protease-activated receptor-1 at the synapse
    Shavit-Stein, E.
    Katzev, A.
    Chapman, J.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (SUPPL 1) : S108 - S108
  • [25] Suppression of ischaemia-induced injuries in rat brain by protease-activated receptor-1 (PAR-1) activating peptide
    Zhen, Xia
    Ng, Ethel Sau Kuen
    Lam, Francis Fu Yuen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 786 : 36 - 46
  • [26] Protease-Activated Receptor (par)-2 Is Required For Par-1 Signaling In Pulmonary Fibrosis
    Lin, C.
    Aberson, H. L.
    Von der Thusen, J.
    Borensztajn, K.
    Spek, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [27] Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis
    Lin, Cong
    von der Thusen, Jan
    Daalhuisen, Joost
    ten Brink, Marieke
    Crestani, Bruno
    van der Poll, Tom
    Borensztajn, Keren
    Spek, C. Arnold
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (06) : 1346 - 1356
  • [28] Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Yamaguchi, Akio
    ANTICANCER RESEARCH, 2008, 28 (2A) : 847 - 854
  • [29] Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats
    Andrade-Gordon, P
    Derian, CK
    Maryanoff, BE
    Zhang, HC
    Addo, MF
    Cheung, WM
    Damiano, BP
    D'Andrea, MR
    Darrow, AL
    De Garavilla, L
    Eckardt, AJ
    Giardino, EC
    Haertlein, BJ
    McComsey, DF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 34 - 42
  • [30] Caveolae are required for protease-selective signaling by protease-activated receptor-1
    Russo, Angela
    Soh, Unice J. K.
    Paing, May M.
    Arora, Puneeta
    Trejo, JoAnn
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (15) : 6393 - 6397
12345